Related references
Note: Only part of the references are listed.
Review
Pharmacology & Pharmacy
Jonathan Andrew Fallowfield et al.
Summary: The number of deaths and prevalent cases of cirrhosis are increasing worldwide, but licensed antifibrotic or pro-regenerative medicines are lacking and liver transplantation is limited. Current research focuses on understanding the cellular and molecular pathogenesis of cirrhosis in order to develop new drugs, with a particular emphasis on NASH-related cirrhosis. Despite obstacles such as a heterogeneous patient population and lack of suitable endpoints, clinical trials are evaluating synthetic drugs for cirrhosis and the NASH field is moving towards a combination drug approach.
EXPERT OPINION ON EMERGING DRUGS
(2021)
Article
Cell Biology
Anne Loft et al.
Summary: Liver fibrosis is a strong predictor of long-term mortality in individuals with metabolic-associated fatty liver disease. The study shows comprehensive alterations in hepatocyte genomic and transcriptional settings during NASH progression, leading to a loss of hepatocyte identity. The reprogramming of hepatocytes is under tight cooperative control of a network of fibrosis-activated transcription factors, promoting hepatocyte dysfunction and directing intra-hepatic crosstalk necessary for NASH and fibrosis progression.
Article
Biotechnology & Applied Microbiology
Jie Zhu et al.
Summary: The study introduces a deep learning-based efficacy prediction system that identifies drug candidates based on changes in gene expression profiles in diseased states. The system was successfully validated on three disorders and showed high predictive accuracy, providing insights into drug repurposing and discovery.
NATURE BIOTECHNOLOGY
(2021)
Article
Biochemistry & Molecular Biology
Aleksandra Deczkowska et al.
Summary: Single-cell analyses reveal cDC1 as conserved immunological drivers of non-alcoholic steatohepatitis in mice and humans. The study identified the significant role of cDC1 in NASH and confirmed their importance in liver pathology.
Article
Multidisciplinary Sciences
Yuzo Koda et al.
Summary: The study identified CD8+ tissue-resident memory T cells as key players in resolving liver fibrosis, potentially through Fas-mediated cytotoxicity to eliminate hepatic stellate cells.
NATURE COMMUNICATIONS
(2021)
Article
Multidisciplinary Sciences
P. Ramachandran et al.
Article
Biochemistry & Molecular Biology
Aravind Subramanian et al.
Review
Pharmacology & Pharmacy
Takaaki Higashi et al.
ADVANCED DRUG DELIVERY REVIEWS
(2017)
Article
Medicine, Research & Experimental
JS Duffield et al.
JOURNAL OF CLINICAL INVESTIGATION
(2005)